EGFR antibody
Ref. 3D-20R-2356
| 50µg | 484,00 € |
Información del producto
The EGFR antibody is a highly specialized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It is designed to inhibit the growth and spread of cancer cells by blocking the interaction between EGFR and its ligands. This antibody has been extensively studied for its potential in treating various types of cancer, including lung, breast, colorectal, and head and neck cancers.
One of the key features of the EGFR antibody is its high specificity and affinity for EGFR. It binds to the receptor with great precision, effectively preventing the activation of downstream signaling pathways that promote cell proliferation and survival. By inhibiting EGFR signaling, this antibody can help slow down tumor growth and improve patient outcomes.
In addition to its anti-tumor effects, the EGFR antibody also exhibits other important properties. It has been shown to enhance the effectiveness of chemotherapy and radiation therapy when used in combination. Furthermore, it can stimulate an immune response against cancer cells by recruiting immune cells to attack tumors.
The
Propiedades químicas
Consulta técnica sobre: 3D-20R-2356 EGFR antibody
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
